{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T14:20:14Z","timestamp":1702736414870},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T00:00:00Z","timestamp":1370995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s11096-013-9803-y","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T02:43:20Z","timestamp":1370918600000},"page":"532-534","source":"Crossref","is-referenced-by-count":5,"title":["Eosinophilia associated with bupropion"],"prefix":"10.1007","volume":"35","author":[{"given":"Montserrat","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Etxegarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unax","family":"Lertxundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,12]]},"reference":[{"key":"9803_CR1","unstructured":"Product Information: WELLBUTRIN\u00ae (bupropion). Research Triangle Park, NC: GlaxoSmithKline. http:\/\/www.pdr.net\/drugpages\/productlabeling.aspx?mpcode=32704625 (2011). Accessed 19 Dec 2012."},{"key":"9803_CR2","unstructured":"Bupropion. DRUGDEX System. Greenwood Village, CO: Thomson Micromedex. Accessed 19 Dec 2012."},{"key":"9803_CR3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/106002809502900907","volume":"29","author":"MA Malesker","year":"1995","unstructured":"Malesker MA, Soori GS, Malone PM, Mahowald JA, Housel GJ. Eosinophilia associated with bupropion. Ann Pharmacother. 1995;29:867\u20139.","journal-title":"Ann Pharmacother"},{"key":"9803_CR4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1081-1206(10)61853-4","volume":"90","author":"SM Bagshaw","year":"2003","unstructured":"Bagshaw SM, Cload B, Gilmour J, Leung ST, Bowen TJ. Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. Ann Allergy Asthma Immunol. 2003;90:572\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9803_CR5","volume-title":"UpToDate","author":"PF Weller","year":"2012","unstructured":"Weller PF. Approach to the patient with eosinophilia. In: Mahoney DH, Bochner BS, editors. UpToDate. UpToDate: Waltham, MA; 2012."},{"key":"9803_CR6","doi-asserted-by":"crossref","unstructured":"Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009. doi: 10.1155\/2009\/495863 .","DOI":"10.1155\/2009\/495863"},{"issue":"7","key":"9803_CR7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","volume":"124","author":"P Cacoub","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588\u201397.","journal-title":"Am J Med"},{"key":"9803_CR8","unstructured":"Australian Database of Adverse Event Notifications. www.tga.gov.au\/daen\/daen-entry.aspx . Accessed 19 Dec 2012."},{"key":"9803_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"9803_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.seminhematol.2012.01.006","volume":"49","author":"R Mejia","year":"2012","unstructured":"Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012;49(2):149\u201359.","journal-title":"Semin Hematol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-013-9803-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9803-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:54:42Z","timestamp":1559354082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-013-9803-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9803"],"URL":"https:\/\/doi.org\/10.1007\/s11096-013-9803-y","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,12]]}}}